Pluri Inc.

Regulatory Filings • Aug 2, 2016

_________ false

�������� ��������� ����	2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001	8543
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	02/08/2016
	www.isa.gov.il			www.tase.co.il				Reference:	2016-02-096160	Time of broadcast: 14:21 14:18:20

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia

FDA_CLI-final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ	Date of revision of form structure: 26/07/2016
Address: Matam Park 20 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: President & Chief Operating Officer Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: yaky@pluristem.com 1